https://www.celeatx.com/leadership-team daily 0.75 2026-07-01 https://www.celeatx.com/leadership-team/sven-dethlefs-phd monthly 0.5 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/1781207763403-8ASUAVNJPF2D84WT7M6E/Sven.jpg Leadership Team - Sven Dethlefs, PhD - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.celeatx.com/leadership-team/david-golod-phd-mba monthly 0.5 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/1781207785798-O2YZ0YRSYGR4ZZT2FR71/David.jpg Leadership Team - David Golod, PhD, MBA - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.celeatx.com/leadership-team/camilla-graham-md-mph monthly 0.5 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/1781207808543-I92AAPAOD3GII06XRHWQ/Camilla.jpg Leadership Team - Camilla Graham, MD, MPH - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.celeatx.com/leadership-team/neera-jain-phd-mba monthly 0.5 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/c3f2784a-a28e-4370-b303-ca0f8bee2361/Neera-NewImage.jpg Leadership Team - Neera Jain, PhD, MBA - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://www.celeatx.com/news-blog daily 0.75 2026-07-01 https://www.celeatx.com/news-blog/deupirfenidone-compared-with-pirfenidone-and-placebo-in-idiopathic-pulmonary-fibrosis-elevate-ipf-a-phase-2b-randomized-placebo-controlled-trial-open-access monthly 0.5 2026-06-11 https://www.celeatx.com/news-blog/puretech-announces-publication-of-phase-2b-elevate-ipf-trial-results-in-the-american-journal-of-respiratory-and-critical-care-medicine monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-announces-orphan-drug-designations-granted-by-the-us-food-and-drug-administration-and-european-commission-for-deupirfenidone-lyt-100-in-idiopathic-pulmonary-fibrosis monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-announces-successful-end-of-phase-2-meeting-with-fda-for-deupirfenidone-lyt-100-in-idiopathic-pulmonary-fibrosis monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-presents-new-phase-2b-analyses-demonstrating-consistent-safety-and-efficacy-of-deupirfenidone-in-older-patients-with-idiopathic-pulmonary-fibrosis-ipf-a-historically-undertreated-group monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-presents-new-data-from-phase-2b-open-label-extension-study-of-deupirfenidone-lyt-100-further-supporting-strong-and-durable-efficacy-and-potential-to-serve-as-new-standard-of-care-in-ipf monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-showcases-differentiated-development-strategy-including-new-patient-preference-insights-and-spotlights-phase-2b-data-positioning-deupirfenidone-as-a-potential-new-standard-of-care-in-ipf monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-announces-the-launch-of-celea-therapeutics-with-a-mission-to-transform-the-treatment-of-respiratory-diseases monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretechs-deupirfenidone-lyt-100-demonstrates-strong-and-durable-efficacy-as-a-monotherapy-with-favorable-tolerability-in-phase-2b-elevate-ipf-trial monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/puretech-announces-publication-of-new-research-highlighting-untold-experiences-of-people-living-with-idiopathic-pulmonary-fibrosis-ipf monthly 0.5 2026-06-10 https://www.celeatx.com/news-blog/perspectives-of-people-living-with-idiopathic-pulmonary-fibrosis-a-qualitative-and-quantitative-study monthly 0.5 2026-06-11 https://www.celeatx.com/news-blog/puretechs-deupirfenidone-lyt-100-slowed-lung-function-decline-in-people-with-idiopathic-pulmonary-fibrosis-ipf-as-measured-by-forced-vital-capacity-fvcachieving-the-primary- monthly 0.5 2026-06-11 https://www.celeatx.com/news-blog/category/Press+Release monthly 0.5 https://www.celeatx.com/news-blog/category/Publication monthly 0.5 https://www.celeatx.com/home daily 1.0 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/b9b79d02-06c4-477c-a026-cbfb7cee246c/Ellipse+2.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/0fdf0010-d9a5-4b20-bd4b-456a0fb8e27e/Group+7370.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/9e20f3b3-5f49-415c-8fda-26dd5e8cb447/Pill+Bottle.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/74b4bbc4-aae2-42e9-a7e6-419597bd01c0/Lungs.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/7af68f60-59ae-4d4e-a6ed-c6539d590567/Graph+Icon.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/eda74936-bfab-4de6-962f-0ff6775e699b/Group+7369.png https://www.celeatx.com/deupirfenidone daily 0.75 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/c43e9032-fc2c-4acb-81db-fc3db4601fa8/Ellipse-6.jpg https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/d46778c9-99c6-4112-aeae-f0932c30c7c1/Ellipse-8.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/b529da9b-77e7-4c8c-82cd-f311374650ec/Group+7370.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/2424a347-99b5-4a2c-a41e-c0987c27223b/Group+7374.png https://www.celeatx.com/patients-and-physicians daily 0.75 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/62df6eac-7329-42d4-8416-6e3ae7863d3c/Group+7381.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/9e20f3b3-5f49-415c-8fda-26dd5e8cb447/Pill+Bottle.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/5f7e5fe0-8390-4f9d-991a-c7ed08521691/gearicon.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/7c79debf-8806-47a3-82ef-c1a630930bde/Ellipse+2.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/c5dc0719-438e-4c36-b08d-fda659c49899/Group+7376.png https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/fb55b9c0-2d0c-4407-a5f1-b178b600ae6c/Rectangle+1751.png https://www.celeatx.com/about-us daily 0.75 2026-07-01 https://images.squarespace-cdn.com/content/v1/68f24efd0976f3155cb544a1/eda74936-bfab-4de6-962f-0ff6775e699b/Group+7369.png https://www.celeatx.com/contact-us daily 0.75 2026-07-01 https://www.celeatx.com/news daily 0.75 2026-07-01 https://www.celeatx.com/expanded-access-policy daily 0.75 2026-07-01